Title

Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic

UMMS Affiliation

Division of Hematology and Oncology, Department of Medicine

Publication Date

2020-07-03

Document Type

Article

Disciplines

Health Services Administration | Hematology | Hemic and Lymphatic Diseases | Immune System Diseases | Infectious Disease | Medical Microbiology | Virus Diseases

Abstract

It is almost six months since novel Coronavirus disease 2019 (COVID-19) started as a local outbreak in Wuhan, China(1) For hematologists and patients suffering from hematological disorders, the COVID-19 pandemic has brought challenges with regards to the diagnosis, treatment, follow-up, office visits, and so on. (2,3) We hereby discuss the current challenges for management of immune thrombocytopenia (ITP) during COVID-19 pandemic, based on our practical experience and interim expert recommendations suggested by the hematology societies.

Keywords

COVID-19, Coronavirus, Epidemiology, Immune responses, Pandemics, Plasma cell, SARS coronavirus, Virus classification

DOI of Published Version

10.1002/jmv.26251

Source

Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic. J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26251. Epub ahead of print. PMID: 32619062. Link to article on publisher's site

Journal/Book/Conference Title

Journal of medical virology

Related Resources

Link to Article in PubMed

PubMed ID

32619062

Share

COinS